BDBM299114 (6S,8S)-6-(2,6-difluoro-4-(2-(3-(fluoromethyl)azetidin-1-yl)ethoxy)phenyl)-8-(difluoromethyl)-7-(2-fluoro-2-methylpropyl)-6-methyl-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinoline::US10125135, Example 4

SMILES CC(C)(F)CN1[C@@H](Cc2c(ccc3[nH]ncc23)[C@@]1(C)c1c(F)cc(OCCN2CC(CF)C2)cc1F)C(F)F

InChI Key InChIKey=KMCKAQHYZDINIC-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 299114   

TargetEstrogen receptor(Human)
Astrazeneca

US Patent
LigandPNGBDBM299114(US10125135, Example 4 | (6S,8S)-6-(2,6-difluoro-4-...)
Affinity DataIC50: 0.5nMAssay Description:The ability of compounds to bind to isolated Estrogen Receptor Alpha Ligand binding domain (ER alpha LBD (GST)) was assessed in competition assays us...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
US Patent